Sign up to save your podcasts
Or
Share Conversations: Will Krawszik, Opportune Therapeutics
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Conversations: Will Krawszik, Opportune Therapeutics
We spoke with Will Krawszik of Opportune Therapeutics about using machine learning to advance the development of psychedelic drugs.
View all episodes
By Report on PsychedelicsWe spoke with Will Krawszik of Opportune Therapeutics about using machine learning to advance the development of psychedelic drugs.